Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Neoplasms × Mirtazapine × Clear all

Phase

Phase 2 2 Phase EARLY_PHASE1 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Depressive Disorder, Major 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 4 Positron Emission Tomography Computed Tomography 3 pembrolizumab 2 Psilocybin 2 Midazolam 2 Methods 2 Ketamine 2 temsirolimus 1 posaconazole 1 poly ICLC 1 parathyroid hormone-related peptide (1-36) 1 lavender oil 1 jojoba wax 1 ginger extract 1 fludarabine phosphate 1 fludarabine 1 fluciclovine F-18 1 evolocumab 1 beta-Glucans 1 Whole-Body Irradiation 1 Varenicline 1 Transplantation 1 Transcranial Direct Current Stimulation 1 Topotecan 1 Tetrahydrouridine 1 Temozolomide 1 Surveys and Questionnaires 1 Stem Cell Transplantation 1 Standard of Care 1 Sodium Chloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01725048 2017-03-13

NRR

UNC Lineberger Comprehensive Cancer Center

Phase EARLY_PHASE1 Completed

Depressive Disorder, Major, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡